327 related articles for article (PubMed ID: 25447585)
21. Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.
Lama VN; Murray S; Mumford JA; Flaherty KR; Chang A; Toews GB; Peters-Golden M; Martinez FJ
Am J Respir Crit Care Med; 2005 Aug; 172(3):379-83. PubMed ID: 15894603
[TBL] [Abstract][Full Text] [Related]
22. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
23. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Hohlfeld J; Niedermeyer J; Hamm H; Schäfers HJ; Wagner TO; Fabel H
J Heart Lung Transplant; 1996 Sep; 15(9):888-94. PubMed ID: 8889984
[TBL] [Abstract][Full Text] [Related]
24. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
25. Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients.
Rajagopalan N; Maurer J; Kesten S
Chest; 1996 Feb; 109(2):405-7. PubMed ID: 8620713
[TBL] [Abstract][Full Text] [Related]
26. Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation.
Winkler A; Kahnert K; Behr J; Neurohr C; Kneidinger N; Hatz R; Dressel H; Radtke T; Jörres RA
Respir Res; 2018 Sep; 19(1):171. PubMed ID: 30200966
[TBL] [Abstract][Full Text] [Related]
27. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
[TBL] [Abstract][Full Text] [Related]
28. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
29. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
Au BK; Au MA; Chien JW
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1072-8. PubMed ID: 21126596
[TBL] [Abstract][Full Text] [Related]
30. Assessment of forced expiratory volume in one second-fraction of the engrafted lung with 133-Xe radiospirometry improves the diagnosis of bronchiolitis obliterans syndrome in single lung transplant recipients.
Ikonen T; Harjula AL; Kinnula VL; Savola J; Sovijärvi A
J Heart Lung Transplant; 1995; 14(2):244-50. PubMed ID: 7779842
[TBL] [Abstract][Full Text] [Related]
31. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
32. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
[TBL] [Abstract][Full Text] [Related]
33. Are we near to an effective drug treatment for bronchiolitis obliterans?
Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
[TBL] [Abstract][Full Text] [Related]
34. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
[TBL] [Abstract][Full Text] [Related]
35. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.
Woodrow JP; Shlobin OA; Barnett SD; Burton N; Nathan SD
J Heart Lung Transplant; 2010 Oct; 29(10):1159-64. PubMed ID: 20580267
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of exhaled nitric oxide measurements for the diagnosis of bronchiolitis obliterans syndrome after lung transplantation.
Verleden GM; Dupont LJ; Van Raemdonck DE; Vanhaecke J;
Transplantation; 2004 Sep; 78(5):730-3. PubMed ID: 15371677
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.
Luckraz H; Sharples L; McNeil K; Wreghitt T; Wallwork J
J Heart Lung Transplant; 2003 Mar; 22(3):287-91. PubMed ID: 12633696
[TBL] [Abstract][Full Text] [Related]
38. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Verleden GM; Dupont LJ; Van Raemdonck DE
Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
[TBL] [Abstract][Full Text] [Related]
39. Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?
Snell GI; Paraskeva M; Westall GP
Paediatr Drugs; 2013 Aug; 15(4):281-9. PubMed ID: 23605986
[TBL] [Abstract][Full Text] [Related]
40. Success of lung transplantation without surveillance bronchoscopy.
Valentine VG; Taylor DE; Dhillon GS; Knower MT; McFadden PM; Fuchs DM; Kantrow SP
J Heart Lung Transplant; 2002 Mar; 21(3):319-26. PubMed ID: 11897519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
